{
    "Trade/Device Name(s)": [
        "Direct Bilirubin LiquiColor",
        "Total Bilirubin LiquiColor"
    ],
    "Submitter Information": "Stanbio Laboratory",
    "510(k) Number": "K050266",
    "Predicate Device Reference 510(k) Number(s)": [
        "K910593",
        "K910591"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JFM"
    ],
    "Summary Letter Date": "June 30, 2005",
    "Summary Letter Received Date": "May 4, 2005",
    "Submission Date": "May 2, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1110"
    ],
    "Regulation Name(s)": [
        "Bilirubin (total or direct) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Direct Bilirubin",
        "Total Bilirubin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzymatic method",
        "Absorbance measurement"
    ],
    "Methodologies": [
        "Enzymatic",
        "Absorbance change quantitation"
    ],
    "Submission Type(s)": [
        "Test system",
        "Reagent",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Stanbio Direct and Total Bilirubin LiquiColor enzymatic test systems for measurement of bilirubin in serum and plasma",
    "Indications for Use Summary": "Intended for measurement of direct and total bilirubin in serum and plasma to assist in diagnosis and treatment of liver, hemolytic, hematological, and metabolic disorders including hepatitis and gall bladder block",
    "fda_folder": "Clinical Chemistry"
}